… proportion of SARS-CoV-2 RNAemia, and an association between RNAemia and clinical …
suggesting the potential utility of plasma viral testing as a prognostic indicator for COVID-19. …

… We calculated the prevalence of SARS-CoV-2 RNAemia from individual studies and then
pooled to estimate the overall prevalence. Random effects model which takes into account the …

… The determinants of coronavirus disease 2019 (COVID-19) disease severity and … acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia and disease severity, …

… RNAemia, antibody response against SARS-CoV-2, and proteomic profiles in serial blood
samples from COVID-19 patients admitted to two … without COVID-19 as well as SARS-CoV-2-…

… SARS-CoV-2 RNAemia is an independent predictor of severe COVID-19. We observed
that … In this study, we further demonstrated that failure of prompt SARS-CoV-2 RNAemia …

… that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients.
… In this study, we quantitatively assessed the dynamics of blood SARS-CoV-2 RNAemia …

… Visualization of virus particles in plasma indicates that SARS-CoV-2 RNAemia is due, at
least in part, to viremia. The levels of SARS-CoV-2 RNAemia quantified by ultrasensitive RT-…

… This study demonstrated a relatively high proportion of SARS-CoV-2 RNAemia and an
association between RNAemia and clinical severity. Moreover, among the patients with RNAemia…

… ‐PCR confirmed SARS‐CoV‐2 infection included in our study only one critically ill
individual had RNAemia. Based on these limited data, there is no measurable risk for SARS‐CoV‐2 …

… This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19 critical
condition development and mortality in comparison with other predictive markers and scoring …